530 related articles for article (PubMed ID: 16850005)
1. Up-regulation of MyD88s and SIGIRR, molecules inhibiting Toll-like receptor signaling, in monocytes from septic patients.
Adib-Conquy M; Adrie C; Fitting C; Gattolliat O; Beyaert R; Cavaillon JM
Crit Care Med; 2006 Sep; 34(9):2377-85. PubMed ID: 16850005
[TBL] [Abstract][Full Text] [Related]
2. Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture.
Uehara A; Yang S; Fujimoto Y; Fukase K; Kusumoto S; Shibata K; Sugawara S; Takada H
Cell Microbiol; 2005 Jan; 7(1):53-61. PubMed ID: 15617523
[TBL] [Abstract][Full Text] [Related]
3. Impaired monocyte Toll-like receptor-4 signaling in trauma and sepsis: is SIGIRR the answer?
Wang JE; Dahle MK; Aasen AO
Crit Care Med; 2006 Sep; 34(9):2498-500. PubMed ID: 16921326
[No Abstract] [Full Text] [Related]
4. Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens.
Skinner NA; MacIsaac CM; Hamilton JA; Visvanathan K
Clin Exp Immunol; 2005 Aug; 141(2):270-8. PubMed ID: 15996191
[TBL] [Abstract][Full Text] [Related]
5. [Role of transduce molecules and modulatory factors of signal pathways of Toll-like receptor in inflammatory response of children with sepsis].
Yang WG; Li CR; He YX; Wang GB; Zu Y
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Sep; 20(9):561-4. PubMed ID: 18786322
[TBL] [Abstract][Full Text] [Related]
6. Bacterial lipoprotein-induced self-tolerance and cross-tolerance to LPS are associated with reduced IRAK-1 expression and MyD88-IRAK complex formation.
Li CH; Wang JH; Redmond HP
J Leukoc Biol; 2006 Apr; 79(4):867-75. PubMed ID: 16461741
[TBL] [Abstract][Full Text] [Related]
7. Expression, regulation, and signaling of the pattern-recognition receptor nucleotide-binding oligomerization domain 2 in rheumatoid arthritis synovial fibroblasts.
Ospelt C; Brentano F; Jüngel A; Rengel Y; Kolling C; Michel BA; Gay RE; Gay S
Arthritis Rheum; 2009 Feb; 60(2):355-63. PubMed ID: 19180502
[TBL] [Abstract][Full Text] [Related]
8. Chemically synthesized pathogen-associated molecular patterns increase the expression of peptidoglycan recognition proteins via toll-like receptors, NOD1 and NOD2 in human oral epithelial cells.
Uehara A; Sugawara Y; Kurata S; Fujimoto Y; Fukase K; Kusumoto S; Satta Y; Sasano T; Sugawara S; Takada H
Cell Microbiol; 2005 May; 7(5):675-86. PubMed ID: 15839897
[TBL] [Abstract][Full Text] [Related]
9. Alterations in inflammatory capacity and TLR expression on monocytes and neutrophils after cardiopulmonary bypass.
Hadley JS; Wang JE; Michaels LC; Dempsey CM; Foster SJ; Thiemermann C; Hinds CJ
Shock; 2007 May; 27(5):466-73. PubMed ID: 17438450
[TBL] [Abstract][Full Text] [Related]
10. CARD15 variants determine a disturbed early response of monocytes to adherent-invasive Escherichia coli strain LF82 in Crohn's disease.
Peeters H; Bogaert S; Laukens D; Rottiers P; De Keyser F; Darfeuille-Michaud A; Glasser AL; Elewaut D; De Vos M
Int J Immunogenet; 2007 Jun; 34(3):181-91. PubMed ID: 17504508
[TBL] [Abstract][Full Text] [Related]
11. Increased surface toll-like receptor 2 expression in superantigen shock.
Hopkins PA; Pridmore AC; Ellmerich S; Fraser JD; Russell HH; Read RC; Sriskandan S
Crit Care Med; 2008 Apr; 36(4):1267-76. PubMed ID: 18379254
[TBL] [Abstract][Full Text] [Related]
12. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration.
Seki E; Tsutsui H; Iimuro Y; Naka T; Son G; Akira S; Kishimoto T; Nakanishi K; Fujimoto J
Hepatology; 2005 Mar; 41(3):443-50. PubMed ID: 15723296
[TBL] [Abstract][Full Text] [Related]
13. Hyper-IgE syndrome is not associated with defects in several candidate toll-like receptor pathway genes.
Hawn TR; Ozinsky A; Williams LM; Rodrigues S; Clark A; Pham U; Hill HR; Ochs H; Aderem A; Liles WC
Hum Immunol; 2005 Jul; 66(7):842-7. PubMed ID: 16112032
[TBL] [Abstract][Full Text] [Related]
14. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists.
Figueiredo MD; Vandenplas ML; Hurley DJ; Moore JN
Vet Immunol Immunopathol; 2009 Jan; 127(1-2):125-34. PubMed ID: 19019456
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of endotoxin activity by muramyldipeptide.
Takada H; Yokoyama S; Yang S
J Endotoxin Res; 2002; 8(5):337-42. PubMed ID: 12537692
[TBL] [Abstract][Full Text] [Related]
16. Bacterial lipopolysaccharide induces increased expression of toll-like receptor (TLR) 4 and downstream TLR signaling molecules in bovine mammary epithelial cells.
Ibeagha-Awemu EM; Lee JW; Ibeagha AE; Bannerman DD; Paape MJ; Zhao X
Vet Res; 2008; 39(2):11. PubMed ID: 18096120
[TBL] [Abstract][Full Text] [Related]
17. Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists.
Fritz JH; Girardin SE; Fitting C; Werts C; Mengin-Lecreulx D; Caroff M; Cavaillon JM; Philpott DJ; Adib-Conquy M
Eur J Immunol; 2005 Aug; 35(8):2459-70. PubMed ID: 16021602
[TBL] [Abstract][Full Text] [Related]
18. Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation.
Li B; Zhang R; Li J; Zhang L; Ding G; Luo P; He S; Dong Y; Jiang W; Lu Y; Cao H; Zheng J; Zhou H
Int Immunopharmacol; 2008 Mar; 8(3):379-89. PubMed ID: 18279792
[TBL] [Abstract][Full Text] [Related]
19. Contribution of phagocytosis and intracellular sensing for cytokine production by Staphylococcus aureus-activated macrophages.
Kapetanovic R; Nahori MA; Balloy V; Fitting C; Philpott DJ; Cavaillon JM; Adib-Conquy M
Infect Immun; 2007 Feb; 75(2):830-7. PubMed ID: 17118979
[TBL] [Abstract][Full Text] [Related]
20. Differential toll-like receptor expression after ex vivo lipopolysaccharide exposure in patients with sepsis and following surgical stress.
Tsujimoto H; Ono S; Majima T; Efron PA; Kinoshita M; Hiraide H; Moldawer LL; Mochizuki H
Clin Immunol; 2006 May; 119(2):180-7. PubMed ID: 16517212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
